Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Implantable pacemaker-cardioconverter-defibrillator]

T Richter1, J Borbola, A Arvay

  • 1Országos Kardiológiai Intézet, Budapest.

Orvosi Hetilap
|February 5, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anaesthetic efficacy and postinduction hypotension with remimazolam compared with propofol: a multicentre randomised controlled trial.

Anaesthesia·2024
Same author

Single chest drain is not inferior to double chest drain after robotic esophagectomy: a propensity score-matched analysis.

Frontiers in surgery·2023
Same author

Drainless robot-assisted minimally invasive oesophagectomy-randomized controlled trial (RESPECT).

Trials·2023
Same author

[Erratum to: Contra: thoracic epidural anesthesia for video-assisted thoracoscopy].

Der Anaesthesist·2020
Same author

[Contra: thoracic epidural anesthesia in video-assisted thoracoscopy].

Der Anaesthesist·2020
Same author

Clinical validation and accuracy testing of a radiographic decision aid for unicondylar knee arthroplasty patient selection in midterm follow-up.

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA·2020
Same journal

[The application of artificial intelligence in healthcare: benefits, challenges, and issues of responsibility].

Orvosi hetilap·2026
Same journal

[Long-COVID syndrome and lung-specific abnormalities following COVID-19].

Orvosi hetilap·2026
Same journal

[Validation of the Vaccination Attitudes Examination (VAX) scale in Hungary].

Orvosi hetilap·2026
Same journal

Orvosi hetilap·2026
Same journal

[The Hungarian short version and psychometric properties of the Activities-specific Balance Confidence Scale for assessing fall risk].

Orvosi hetilap·2026
Same journal

[Hungarian primary care: facts, problems and expectations].

Orvosi hetilap·2026
See all related articles

The first automatic, implantable cardioverter-defibrillator (AICD) implantations in Hungary successfully treated ventricular arrhythmias. AICD therapy significantly reduces the risk of sudden cardiac death in high-risk patients.

Area of Science:

  • Cardiology
  • Medical Devices

Background:

  • The article introduces the automatic, implantable cardioverter-defibrillator (AICD) device.
  • It details the indications for AICD implantation in the European Community, including recurrent ventricular tachycardia/fibrillation or aborted sudden cardiac death unresponsive to other treatments.

Observation:

  • The first AICD implantation in Hungary occurred on January 8, 1992.
  • The first patient, with dilatative cardiomyopathy, experienced 16 successful defibrillator discharges but had limited survival due to disease progression.
  • The second patient underwent successful surgery and AICD function, with successful termination of spontaneous ventricular tachycardia.

Findings:

  • AICD implantation is not a causative treatment and is associated with high costs.
  • The AICD device demonstrated successful defibrillation and termination of ventricular arrhythmias in both cases.

Related Experiment Videos

  • AICD treatment was shown to considerably decrease the risk of sudden cardiac (arrhythmic) deaths.
  • Implications:

    • This introduces AICD therapy to Hungary, offering a crucial intervention for preventing sudden cardiac death.
    • The successful cases highlight the potential of AICD to manage life-threatening ventricular arrhythmias.
    • Further research may explore cost-effectiveness and long-term outcomes of AICD in the Hungarian population.